Religox bi-fold Brochure

This bi-fold brochure cover page highlights the impact of advanced prostate cancer on daily life with the slogan "DARE TO CHALLENGE." Promotes the treatment GnRHa to help patients resume normal activities. In the middle pages introduces Religox (Relugolix, 120 mg) as a hormone therapy that effectively reduces testosterone, supported by the HERO study. Shows significant reductions in PSA levels and sustained testosterone suppression. Lastly back page is features a smiling patient, emphasizing Relugolix's benefits. Includes prescribing information and highlights the drug's effectiveness and usage for advanced prostate cancer.

Here is the link : https://www.behance.net/gallery/187398891/Religox-Bi-fold-Brochure